James Herrmann is a Dermatology physician affiliated with Unisys. OpenAlex indexes 10 publications with 503 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
199 Town Sq
Ste A
Wheaton, IL 601873878
Telephone
630-871-6690Provider last certified this registry record 8 Aug 2023.
Industry payments
20 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202514 payments$17,778openpaymentsdata.cms.gov ↗
- Novartis Pharmaceuticals CorporationProgram year20256 payments
- Galderma Laboratories, L.P.Program year202513 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
32.9%Corticosteroid32.9%Triamcinolone Acetonide50%Triamcinolone acetonide50%Part D + Part B≥48 patientsCancer & immunology
30.5%Porphyrin Precursor15.6%Aminolevulinic acid hcl100%Part B, office-administered≥45 patientsNucleoside Metabolic Inhibitor8.7%Fluorouracil100%Part D≥25 patients+ 2 more classes in this area
Anti-infectives
18.4%Tetracycline-class Drug7.3%Doxycycline Monohydrate55%Doxycycline Hyclate45%Part D<11 patientsAzole Antifungal5.9%Ketoconazole100%Part D≥12 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Treatment of mycosis fungoides with photochemotherapy (PUVA): Long-term follow-up
Journal of the American Academy of Dermatology
1995 - Effectiveness of interferon alfa-2a combined with phototherapy for mycosis fungoides and the Sézary syndrome.
Journal of Clinical Oncology
1995 - Ultraviolet Radiation for Treatment of Cutaneous T-cell Lymphoma
Hematology/Oncology Clinics of North America
1995
Similar KOLs
Other experts from the same institution or the same specialty.
Hywel C Williams
University of Nottingham
Mohsen Afarideh, MD, MPH
Mayo Clinic
Brigitte Dréno
Centre National de la Recherche Scientifique
Giovanni Damiani
University of Milan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”